BEXSERO susp inj ser pré 0.5 ml
7680657300031
CH-65730
J07AH09
08.08.
1 / 3
google
Details
- Product number
- 6573001
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- proteinum fusionatum NHBA neisseriae meningitidis B 50 µg, proteinum NadA neisseriae meningitidis B 50 µg, proteinum fusionatum fHbp neisseriae meningitidis B 50 µg, vesicula membranae exterioris (OMV) ex Neisseria meningitidis B (Stamm: NZ98/254) 25 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, histidinum, natrii chloridum, saccharum, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.2 mg.
Articles (1)
Bexsero, Injektionssuspension
Injektionssuspension
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
proteinum fusionatum NHBA neisseriae meningitidis B
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum NadA neisseriae meningitidis B
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
proteinum fusionatum fHbp neisseriae meningitidis B
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
|
vesicula membranae exterioris (OMV) ex Neisseria meningitidis B
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
0.5 MG | Substance | HNIDK |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
histidinum
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
1.2 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 98.70
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2023
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 65730
- Drug name
- Bexsero, Injektionssuspension
- Galenic form
- INJFS
- ATC Code
- J07AH09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/11/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BEXSERO susp inj ser pré 0.5 ml
- Description (DE)
- BEXSERO Inj Susp Fertspr 0.5 ml
- Market launch
- 23/11/2017
- Narcotic (BTM)
- No